Tag Archives: Prostate cancer

‘Movember’ to raise awareness of men’s cancer

If you hear the word “Movember,” it’s not a mispronunciation or misspelling. 

The idea for Movember, which, according to one website, was sparked over a few beers in Melbourne, Australia, back in 2003, is for men around the globe to grow a mustache — and raise money for cancer research, as well as raise awareness about cancers that affect men.

“Mo Bros,” as the site calls them, start the month cleanshaven and register at Movember.com (registration is still open). Throughout the month, men grow their mustaches to raise awareness and gather donations for their Movember account.

 The donations in the United States go to benefit research for better treatments and a cure for prostate cancer through the Prostate Cancer Foundation and for young adults with cancer through LIVESTRONG Young Adult Alliance.

For men out there who can’t quite grow their mustache out to fulfill the ridiculously high expectations set by the likes of Tom Selleck and Geraldo Rivera, and women who want to help, you can donate to an individual or a team, or make a general donation at Movember’s website.

In 2004, the first year of raising awareness and funding through Movember, 432 participants raised $55,000. Last year, more than 250,000 participants raised $42 million.

Prostate cancer drug may be on market soon

For the first time, an experimental drug has extended the lives of men with advanced prostate cancer who are no longer responding to other treatments and are out of options for fighting the disease, a company-led study found.

The benefit was modest — an extra 10 weeks — but cancer specialists were excited because no chemotherapy until now has been shown to boost survival in such men, the Eau Claire (Wis.) Leader-Telegram reported. And like any new drug tested on worst-case patients, there are hopes it will do better when tested in men who aren’t as sick.

The drug is cabazitaxel, made by the French company Sanofi-Aventis SA. The federal Food and Drug Administration  said it will give it a quick review, which means it could be on the market soon.